ResVita Bio
Developer of skin probiotics intended to treat chronic skin diseases. The company is developing a versatile skin microbial platform by using synthetic biology and metabolic engineering that continuously delivers therapies that can ease inflammation, rebuild damaged tissue, and remove harmful bacteria, providing users with faster and more efficient alternatives for the treatment of chronic skin…
Read MoreReRx Therapeutics
Developer of oral therapeutics intended to transfer clinical outcomes of patients with severe metabolic disorders. The company targets severe metabolic diseases like Obesity, Type 2 Diabetes Mellitus, Metabolic Syndrome, and NASH/NAFLD, enabling doctors to improve clinical outcomes for ACC inhibition.
Read MoreRareterra
Developer of an acid-free microbial bioprocess intended to recover and separate rare-earth elements (REEs) from complex and waste sources. The company’s technology leverages advanced genetic and metabolic engineering techniques to optimize microbial strains, enabling recycling industries to reduce the negative impacts on local communities and improve environmental sustainability.
Read MoreQUiCKR Bio
QUiCKR Bio builds tools to provide Instant Quantification of genetic modifications for Cell and Gene Therapy researchers.
Read MoreProtocols.io
Developer of an open-access platform designed to share and discover life science protocols. The company’s platform leverages mobile and web technology to create a global online community of scientists and gives a structured way to create and modify protocols in minutes, enabling scientists to improve their existing methods without the ability to share the improvements…
Read MorePrellis Biologics
Developer of a bioprinting technology designed to recreate and engineer human tissues in vitro. The company’s technology precisely reproduces the human immune response through the creation of lymph node organoids and can exploit fully human immune responses for a variety of applications, including antibody discovery, immunogenicity assessment, and tumor-immune models, improving patients’ lives by addressing…
Read MorePraio
Praio enables economical manufacture commodity chemicals using synthetic protocells with a reduced carbon footprint.
Read MorePositivo Biotechnology LLC
A company focused on developing non-viral DNA gene delivery and expression systems for treating various diseases, including cystic fibrosis. Their technology aims to overcome challenges in traditional gene therapies, such as immune responses and toxicity, by delivering and expressing DNA-encoded therapeutics more safely and effectively
Read MorePOG CONSULTING INC
BIOTECH CONSULTING-coordinating, across disciplines, the research, manufacturing and development of novel therapeutics.
Read MorePLATFORM2THERAPEUTICS LLC
Business Consulting
Read More